ICOC Meeting Agenda

Return to CIRM Meetings and Events

MEETING NOTICE AND AGENDA
REGULAR MEETING OF THE
INDEPENDENT CITIZENS OVERSIGHT COMMITTEE
CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE AND
THE APPLICATION REVIEW SUBCOMMITTEE
Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Wednesday, January 29, 2014
9:00 am – 5:00 pm

Main Location
Claremont Hotel
41 Tunnel Road
Berkeley, CA 94705

Other Locations
The Scripps Research Institute
3301 North Torrey Pines Court
La Jolla, CA 92037

3121 Las Vegas Blvd South – SITE NO LONGER AVAILABLE
Las Vegas, NV

Cedars-Sinai Medical Center
8700 Beverly Blvd.   Davis 5090
Los Angeles, CA 90048

Dial Information:
Dial In Number: (866) 254-5935
Confirmation Number: 317421

Audio Cast:
To access the live event or archive, use this URL:
https://im.csgsystems.com/cgi-bin/confCast
Enter Conference ID# 317421. 
Then click Go.

WebEx Info
——————————————————-
To join the event as an attendee
——————————————————-
1. Go to https://cirm.webex.com/cirm/onstage/g.php?d=805281818&t=a&EA=acheung%40cirm.ca.gov&ET=173324ae78a10f8470757bc9d9b4e06b&ETR=621269282d2d50e23b524a8e64809f66&SourceId=f0a815aea27c3a64e040fc0a6907cf48&RT=MiM0&p
2. Click “Join Now”.

[Members of the Public will be invited to provide testimony before or during consideration of each item. Makers of public comments are asked to limit their testimony to three (3) minutes.]

REPORTS & DISCUSSION ITEMS

1. Call to Order.

2. Pledge of Allegiance.

3. Oath of Office for new board members.

4. Roll Call.

5. Chairman’s Report.

6. President’s Report.

ACTION ITEMS

7. Consideration of applications for RFA 12-06: CIRM Stem Cell Genomics Centers of Excellence Awards.

8. Consideration of applications for RFA 13-02: CIRM Basic Biology Awards V.

9. Consideration of Appointment of new members to the Medical and Ethical Standards Working Group. (PDF)

10. Consideration of initiating rulemaking for amendment of section 100070 of the CIRM Medical and Ethical Standards. (PDF)

11. Consideration of resolution honoring Michael Goldberg. (PDF)

12. Consideration of candidate position statement for President. (PDF)

CLOSED SESSION

13. Discussion of confidential intellectual property or work product, prepublication data, financial information, confidential scientific research or data, and other proprietary information relating to applications for RFA 12-06: CIRM Stem Cell Genomics Centers of Excellence Awards, and for RFA 13-02: CIRM Basic Biology Awards V.  (Health & Safety Code 125290.30(f) (3) (B) and (C)).

14. Discussion of Personnel [Presidential Search] (Government Code section 11126,    subdivision (a); Health & Safety Code section 125290.30(f) (3) (D)).

ACTION ITEMS

15. Consideration of minutes from the December 2013 ICOC Board Meeting.

DISCUSSION ITEMS

16. Communications Update.

17. Public comment.  The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Maria Bonneville at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Maria Bonneville at the California Institute for Regenerative Medicine at mbonneville@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.

Date Published: January 17, 2014
Last Modified: November 5, 2019